ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE0002W8NB38
Stock Name / FundiShares MSCI USA Swap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF TickerMUSD(EUR) AS
ETF TickerMUSD(USD) Euronext Amsterdam
ETF TickerMUSA(EUR) Euronext Paris

Holdings detail for BMRN

Stock NameBiomarin Pharmaceutical Inc
TickerBMRN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS09061G1013
LEINSLL8ITTRR0J5HEMR848

Show aggregate BMRN holdings

News associated with BMRN

BioMarin Pharmaceutical (NASDAQ:BMRN) Coverage Initiated at HC Wainwright
HC Wainwright assumed coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) in a note issued to investors on Monday, MarketBeat.com reports. The firm set a “neutral” rating and a $60.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 7.74% from the stock’s previous […] - 2025-09-10 03:13:10
Predicting the Next Rule Breaker Buyout
In this Motley Fool Money podcast, Motley Fool analyst Karl Thiel and contributors Rick Munarriz and Jason Hall dig into four growth stocks ripe for the acquiring. There's also two sides to Tesla's changing AI story and a new kind of stock quote game. - 2025-08-19 01:08:00
9,709 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Atria Wealth Solutions Inc.
Atria Wealth Solutions Inc. bought a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 9,709 shares of the biotechnology company’s stock, valued at approximately $686,000. Several other hedge funds and other institutional investors also […] - 2025-08-13 04:49:08
Natixis Advisors LLC Grows Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Natixis Advisors LLC raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 68.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,226 shares of the biotechnology company’s stock after buying an additional 13,488 shares during the quarter. Natixis Advisors […] - 2025-08-08 07:20:44
Guggenheim Issues Positive Forecast for BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) had its target price hoisted by investment analysts at Guggenheim from $101.00 to $106.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Guggenheim’s price objective indicates a potential upside of 78.27% from the company’s current […] - 2025-08-08 04:26:58
BMRN Makes Bullish Cross Above Critical Moving Average
In trading on Tuesday, shares of BioMarin Pharmaceutical Inc (Symbol: BMRN) crossed above their 200 day moving average of $63.38, changing hands as high as $63.97 per share. BioMarin Pharmaceutical Inc shares are currently trading up about 5.7% on the day. The chart below show - 2025-08-05 12:47:37
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $93.74 Average Target Price from Analysts
Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-four research firms that are presently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and eighteen have given a buy recommendation to the company. […] - 2025-08-05 02:55:15
Biomarin Pharmaceutical Q2 25 Earnings Conference Call At 4:30 PM ET
(RTTNews) - Biomarin Pharmaceutical Inc. (BMRN) will host a conference call at 4:30 PM ET on August 4, 2025, to discuss Q2 25 earnings results. - 2025-08-04 08:30:49
Signaturefd LLC Increases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Signaturefd LLC boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 19.1% during the 1st quarter, Holdings Channel reports. The institutional investor owned 2,191 shares of the biotechnology company’s stock after acquiring an additional 352 shares during the period. Signaturefd LLC’s holdings in BioMarin Pharmaceutical were worth $155,000 as of […] - 2025-07-21 05:36:50
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Nisa Investment Advisors LLC
Nisa Investment Advisors LLC lifted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 5.0% in the first quarter, Holdings Channel reports. The firm owned 4,572 shares of the biotechnology company’s stock after buying an additional 217 shares during the period. Nisa Investment Advisors LLC’s holdings in BioMarin Pharmaceutical were worth $323,000 as […] - 2025-07-17 06:25:00
Cerity Partners LLC Raises Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Cerity Partners LLC raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 203.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 84,832 shares of the biotechnology company’s stock after acquiring an additional 56,897 shares during the period. […] - 2025-07-17 05:51:03
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Raised to $113.00
BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price objective upped by JPMorgan Chase & Co. from $108.00 to $113.00 in a research report sent to investors on Monday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the biotechnology company’s stock. Other equities analysts have also issued research reports about the […] - 2025-07-17 04:48:52
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought by Xponance Inc.
Xponance Inc. raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 31,877 shares of the biotechnology company’s stock after buying an additional 202 shares during the quarter. Xponance Inc.’s holdings in BioMarin Pharmaceutical were worth […] - 2025-07-15 07:02:50
D.A. Davidson & CO. Has $480,000 Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
D.A. Davidson & CO. lessened its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 9.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,788 shares of the biotechnology company’s stock after selling 746 shares during the quarter. D.A. Davidson […] - 2025-07-11 05:32:53
Brokerages Set BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) PT at $93.61
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. The average 1 […] - 2025-07-11 02:56:50
Principal Financial Group Inc. Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Principal Financial Group Inc. lifted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 455,485 shares of the biotechnology company’s stock after purchasing an additional 1,549 shares during […] - 2025-07-08 06:26:49
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. lowered its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.6% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 467,245 shares of the biotechnology company’s stock after selling 2,798 shares during the period. Sumitomo Mitsui Trust Group […] - 2025-07-03 06:13:02
Bessemer Group Inc. Has $327,000 Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Bessemer Group Inc. reduced its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,618 shares of the biotechnology company’s stock after selling 683 shares during the quarter. Bessemer Group Inc.’s […] - 2025-07-03 05:00:50
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Robeco Institutional Asset Management B.V.
Robeco Institutional Asset Management B.V. boosted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.3% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 97,261 shares of the biotechnology company’s stock after purchasing an additional 10,687 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in BioMarin Pharmaceutical were […] - 2025-06-30 05:06:50
Kentucky Retirement Systems Insurance Trust Fund Acquires New Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 5,490 shares of the biotechnology company’s stock, valued at approximately $388,000. A number of other institutional investors have also […] - 2025-06-26 05:04:54
Kentucky Retirement Systems Buys New Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Kentucky Retirement Systems bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, HoldingsChannel.com reports. The institutional investor bought 12,890 shares of the biotechnology company’s stock, valued at approximately $911,000. Other hedge funds have also recently added to or reduced their stakes in the company. Farther Finance […] - 2025-06-25 05:40:49
Exchange Traded Concepts LLC Acquires 979 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Exchange Traded Concepts LLC boosted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 5.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,796 shares of the biotechnology company’s stock after acquiring an additional 979 shares during the quarter. Exchange Traded […] - 2025-06-19 04:58:54
Mn Services Vermogensbeheer B.V. Boosts Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Mn Services Vermogensbeheer B.V. increased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.0% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 35,500 shares of the biotechnology company’s stock after buying an additional 3,800 shares during the period. Mn Services Vermogensbeheer […] - 2025-06-18 05:44:54
NorthCrest Asset Manangement LLC Acquires Shares of 4,885 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
NorthCrest Asset Manangement LLC acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 4,885 shares of the biotechnology company’s stock, valued at approximately $345,000. Other hedge funds and […] - 2025-06-16 05:36:54
UMB Bank n.a. Increases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
UMB Bank n.a. grew its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 120.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,247 shares of the biotechnology company’s stock after acquiring an additional 1,228 shares during the period. UMB Bank […] - 2025-06-12 05:32:57
Gateway Investment Advisers LLC Cuts Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Gateway Investment Advisers LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 22.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,512 shares of the biotechnology company’s stock after selling 1,003 shares during the period. Gateway Investment Advisers LLC’s […] - 2025-06-10 05:26:59
Here Are All 6 Stocks I've Bought Through 5 Months of 2025
It's been a wild ride for the stock market through the first five months of 2025. As of mid-February, Wall Street's major stock indexes could do no wrong, with the benchmark S&P 500 vaulting to an all-time record-closing high. But over the next two months, tariff-related unce - 2025-06-05 04:06:00
Tidal Investments LLC Sells 17,428 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Tidal Investments LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 57.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,039 shares of the biotechnology company’s stock after selling 17,428 shares during the quarter. Tidal Investments LLC’s holdings in BioMarin […] - 2025-05-27 05:21:04
Quantinno Capital Management LP Purchases Shares of 5,848 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Quantinno Capital Management LP bought a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 5,848 shares of the biotechnology company’s stock, valued at approximately $384,000. A number […] - 2025-05-26 04:58:58
Analysts See 10% Upside For The Holdings of ILCB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:58:34

iShares MSCI USA Swap UCITS ETF USD (Acc) BMRN holdings

DateNumber of BMRN Shares HeldBase Market Value of BMRN SharesLocal Market Value of BMRN SharesChange in BMRN Shares HeldChange in BMRN Base ValueCurrent Price per BMRN Share HeldPrevious Price per BMRN Share Held
2025-11-27 (Thursday)60,921BMRN holding increased by 121842USD 3,382,334BMRN holding increased by 6764668USD 3,382,334121,842USD 6,764,668 USD 55.52 USD 0
2025-11-27 (Thursday)-60,921BMRN holding increased by 121842USD -3,382,334BMRN holding increased by 6764668USD -3,382,334121,842USD 6,764,668 USD 55.52 USD 0
2025-11-26 (Wednesday)60,921BMRN holding increased by 121842USD 3,382,334BMRN holding increased by 6811577USD 3,382,334121,842USD 6,811,577 USD 55.52 USD 0
2025-11-26 (Wednesday)-60,921BMRN holding increased by 121842USD -3,382,334BMRN holding increased by 6811577USD -3,382,334121,842USD 6,811,577 USD 55.52 USD 0
2025-11-25 (Tuesday)60,921BMRN holding increased by 121842USD 3,429,243BMRN holding increased by 6810359USD 3,429,243121,842USD 6,810,359 USD 56.29 USD 0
2025-11-25 (Tuesday)-60,921BMRN holding increased by 121842USD -3,429,243BMRN holding increased by 6810359USD -3,429,243121,842USD 6,810,359 USD 56.29 USD 0
2025-11-24 (Monday)60,921BMRN holding increased by 121842USD 3,381,116BMRN holding increased by 6712885USD 3,381,116121,842USD 6,712,885 USD 55.5 USD 0
2025-11-24 (Monday)-60,921BMRN holding increased by 121842USD -3,381,116BMRN holding increased by 6712885USD -3,381,116121,842USD 6,712,885 USD 55.5 USD 0
2025-11-21 (Friday)60,921BMRN holding increased by 121842USD 3,331,769BMRN holding increased by 6528903USD 3,331,769121,842USD 6,528,903 USD 54.69 USD 0
2025-11-21 (Friday)-60,921BMRN holding increased by 121842USD -3,331,769BMRN holding increased by 6528903USD -3,331,769121,842USD 6,528,903 USD 54.69 USD 0
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BMRN by Blackrock for IE0002W8NB38

Show aggregate share trades of BMRN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-27BUY121,842 55.520* 58.84
2025-11-26BUY121,84256.39054.510 54.698USD 6,664,514 58.86
2025-11-26BUY121,84256.39054.510 54.698USD 6,664,514 58.86
2025-11-25BUY121,84256.45055.350 55.460USD 6,757,357 58.88
2025-11-24BUY121,84256.13053.930 54.150USD 6,597,744 58.90
2025-11-21BUY121,84254.75052.505 52.730USD 6,424,668 58.93
2025-11-20BUY121,84253.72552.360 52.497USD 6,396,279 58.97
2025-11-19BUY121,84253.88052.000 52.188USD 6,358,690 59.02
2025-11-18BUY121,84254.52052.910 53.071USD 6,466,277 59.05
2025-11-17BUY121,84255.24054.000 54.124USD 6,594,576 59.08
2025-11-14BUY121,84255.29553.670 53.832USD 6,559,059 59.11
2025-11-13BUY121,84255.33054.160 54.277USD 6,613,218 59.14
2025-11-12BUY121,84255.33054.305 54.408USD 6,629,119 59.17
2025-11-11BUY121,84254.97052.855 53.066USD 6,465,728 59.20
2025-11-10BUY121,84252.80051.810 51.909USD 6,324,697 59.24
2025-11-07BUY121,84251.90050.760 50.874USD 6,198,590 59.30
2025-11-06BUY121,84252.68051.425 51.550USD 6,281,016 59.35
2025-11-05BUY121,84253.49051.860 52.023USD 6,338,586 59.40
2025-11-04BUY121,84252.76051.800 51.896USD 6,323,112 59.44
2025-11-03BUY121,84254.25052.060 52.279USD 6,369,777 59.49
2025-10-31BUY121,84253.62051.020 51.280USD 6,248,058 59.54
2025-10-30BUY121,84252.48551.143 51.277USD 6,247,728 59.59
2025-10-29BUY121,84251.86054.750 54.461USD 6,635,637 59.65
2025-10-28BUY121,84253.49056.800 56.469USD 6,880,296 59.69
2025-10-27BUY121,84252.67055.840 55.523USD 6,765,033 59.75
2025-10-24BUY121,84254.48055.030 54.975USD 6,698,264 59.79
2025-10-23BUY121,84254.55054.610 54.604USD 6,653,061 59.83
2025-10-22BUY121,84253.37054.410 54.306USD 6,616,752 59.87
2025-10-21BUY121,84253.81053.980 53.963USD 6,574,960 59.92
2025-10-20BUY121,84253.07053.550 53.502USD 6,518,791 59.97
2025-10-17BUY121,84253.29053.490 53.470USD 6,514,892 60.03
2025-10-16BUY121,84252.95053.960 53.859USD 6,562,288 60.08
2025-10-15BUY121,84253.09053.760 53.693USD 6,542,062 60.14
2025-10-14BUY121,84252.47052.810 52.776USD 6,430,334 60.20
2025-10-13SELL-121,84252.45052.900 52.855USD -6,439,959 59.98 Profit of 867,898 on sale
2025-10-09BUY121,84253.85055.390 55.236USD 6,730,065 60.03
2025-10-07BUY121,84254.70056.260 56.104USD 6,835,823 60.07
2025-10-06BUY121,84255.61056.060 56.015USD 6,824,980 60.11
2025-10-03BUY121,84255.43056.000 55.943USD 6,816,207 60.15
2025-10-02BUY121,84255.57055.990 55.948USD 6,816,816 60.19
2025-10-01BUY121,84254.86055.750 55.661USD 6,781,848 60.23
2025-09-30BUY121,84254.16054.420 54.394USD 6,627,474 60.28
2025-09-29BUY121,84254.02054.380 54.344USD 6,621,382 60.34
2025-09-26BUY121,84253.85053.970 53.958USD 6,574,351 60.39
2025-09-25BUY121,84252.62054.500 54.312USD 6,617,483 60.46
2025-09-24SELL-121,84253.77053.870 53.860USD -6,562,410 60.27 Profit of 781,492 on sale
2025-09-18BUY121,84255.14055.220 55.212USD 6,727,141 60.32
2025-09-17BUY121,84254.37055.180 55.099USD 6,713,372 60.37
2025-09-16BUY121,84253.94054.420 54.372USD 6,624,793 60.43
2025-09-15BUY121,84253.14054.390 54.265USD 6,611,756 60.50
2025-09-12BUY121,84254.09056.070 55.872USD 6,807,556 60.56
2025-09-11SELL-121,84255.91055.950 55.946USD -6,816,573 60.32 Profit of 532,982 on sale
2025-09-10BUY121,84254.50055.520 55.418USD 6,752,240 60.38
2025-09-09BUY121,84255.69056.500 56.419USD 6,874,204 60.42
2025-09-08BUY121,84256.38057.770 57.631USD 7,021,876 60.46
2025-09-05BUY121,84257.77058.030 58.004USD 7,067,323 60.48
2025-09-04BUY121,84256.75058.910 58.694USD 7,151,394 60.52
2025-09-02BUY121,84259.09059.240 59.225USD 7,216,093 60.54
2025-08-29SELL-121,84258.27058.350 58.342USD -7,108,506 60.22 Profit of 228,673 on sale
2025-08-28BUY121,84257.68058.640 58.544USD 7,133,118 60.24
2025-08-27BUY121,84258.66058.800 58.786USD 7,162,604 60.26
2025-08-26BUY64,22257.45058.730 58.602USD 3,763,538 60.29
2025-08-22SELL-6,60258.58058.860 58.832USD -388,409 59.97 Profit of 7,497 on sale
2025-08-21BUY6,60258.07058.680 58.619USD 387,003 59.99
2025-08-20BUY6,60257.96058.700 58.626USD 387,049 60.01
2025-08-19BUY6,60257.31058.140 58.057USD 383,292 60.04
2025-08-18BUY6,60257.44058.350 58.259USD 384,626 60.07
2025-08-15BUY6,60257.54059.090 58.935USD 389,089 60.09
2025-08-14BUY6,60258.00058.120 58.108USD 383,629 60.12
2025-08-13BUY6,60258.30058.620 58.588USD 386,798 60.14
2025-08-12BUY6,60256.86057.460 57.400USD 378,955 60.18
2025-08-11SELL-6,60256.80057.630 57.547USD -379,925 59.89 Profit of 15,473 on sale
2025-08-08BUY6,60257.33060.090 59.814USD 394,892 59.92
2025-08-07BUY6,60259.46061.000 60.846USD 401,705 59.93
2025-08-06BUY6,60260.67061.750 61.642USD 406,960 59.92
2025-08-05BUY6,60261.93063.970 63.766USD 420,983 59.89
2025-08-04BUY6,60260.31060.630 60.598USD 400,068 59.89
2025-08-01BUY6,60258.14058.190 58.185USD 384,137 59.91
2025-07-31BUY6,60257.85059.010 58.894USD 388,818 59.94
2025-07-30BUY6,60258.81059.620 59.539USD 393,076 59.95
2025-07-29BUY6,60258.23058.650 58.608USD 386,930 59.97
2025-07-28BUY6,60258.14059.400 59.274USD 391,327 60.00
2025-07-25BUY6,60259.01060.090 59.982USD 396,001 60.01
2025-07-24BUY6,60259.76060.290 60.237USD 397,685 60.01
2025-07-23BUY6,60259.67060.430 60.354USD 398,457 60.02
2025-07-22BUY6,60259.20059.220 59.218USD 390,957 60.03
2025-07-21BUY6,60256.56057.550 57.451USD 379,291 60.08
2025-07-18BUY6,60257.29058.790 58.640USD 387,141 60.11
2025-07-17BUY6,60258.37059.350 59.252USD 391,182 60.14
2025-07-16BUY6,60258.39058.580 58.561USD 386,620 60.16
2025-07-15BUY6,60256.62058.670 58.465USD 385,986 60.22
2025-07-14SELL-6,60258.23058.980 58.905USD -388,891 60.11 Profit of 7,955 on sale
2025-07-11BUY6,60258.10058.500 58.460USD 385,953 60.14
2025-07-10BUY6,60258.82059.570 59.495USD 392,786 60.16
2025-07-09BUY6,60259.67059.980 59.949USD 395,783 60.17
2025-07-08BUY6,60257.99059.370 59.232USD 391,050 60.20
2025-07-07BUY6,60257.41058.000 57.941USD 382,526 60.25
2025-07-04BUY6,602 57.500* 60.29
2025-07-03BUY6,60257.50058.070 58.013USD 383,002 60.34
2025-07-02BUY6,60257.17057.610 57.566USD 380,051 60.39
2025-06-30BUY6,60254.97055.960 55.861USD 368,794 60.49
2025-06-27BUY6,60255.17055.200 55.197USD 364,411 60.58
2025-06-26BUY6,60254.10054.550 54.505USD 359,842 60.70
2025-06-25BUY6,60254.14054.610 54.563USD 360,225 60.82
2025-06-24BUY6,60254.69054.860 54.843USD 362,073 60.93
2025-06-23BUY6,60254.08056.000 55.808USD 368,444 61.06
2025-06-20BUY6,60255.00056.250 56.125USD 370,537 61.17
2025-06-19BUY6,602 55.240* 61.29
2025-06-18BUY6,60255.24055.770 55.717USD 367,844 61.41
2025-06-17BUY6,60255.00056.280 56.152USD 370,715 61.54
2025-06-16BUY6,60256.24056.510 56.483USD 372,901 61.65
2025-06-13BUY6,60256.22057.360 57.246USD 377,938 61.77
2025-06-12BUY6,60257.28057.650 57.613USD 380,361 61.87
2025-06-11BUY6,60257.16057.990 57.907USD 382,302 61.97
2025-06-10BUY6,60257.48058.170 58.101USD 383,583 62.07
2025-06-09BUY6,60256.88057.460 57.402USD 378,968 62.19
2025-06-06BUY6,60256.65057.810 57.694USD 380,896 62.33
2025-06-04BUY6,60256.11057.570 57.424USD 379,113 62.48
2025-06-03BUY6,60256.79057.810 57.708USD 380,988 62.62
2025-06-02BUY6,60257.05058.590 58.436USD 385,794 62.76
2025-05-30BUY6,60258.07058.480 58.439USD 385,814 62.89
2025-05-29BUY6,60258.55058.750 58.730USD 387,735 63.00
2025-05-28BUY6,60258.09059.120 59.017USD 389,630 63.14
2025-05-27BUY6,60258.11058.610 58.560USD 386,613 63.28
2025-05-26BUY6,602 57.550* 63.45
2025-05-23BUY6,60257.55057.840 57.811USD 381,668 63.63
2025-05-22BUY6,60258.01058.400 58.361USD 385,299 63.81
2025-05-21BUY6,60258.48059.510 59.407USD 392,205 63.98
2025-05-20BUY6,60259.93060.480 60.425USD 398,926 64.11
2025-05-19BUY6,60259.41060.000 59.941USD 395,730 64.27
2025-05-16BUY6,60259.27059.730 59.684USD 394,034 64.45
2025-05-15BUY6,60258.27058.940 58.873USD 388,680 64.68
2025-05-14BUY6,60258.70060.030 59.897USD 395,440 64.91
2025-05-13BUY13,16659.78061.300 61.148USD 805,075 65.12
2025-05-12BUY19,73061.37062.300 62.207USD 1,227,344 65.27
2025-05-09BUY19,73058.86060.660 60.480USD 1,193,270 65.55
2025-05-08BUY19,73059.82061.260 61.116USD 1,205,819 65.81
2025-05-07BUY19,73059.32060.160 60.076USD 1,185,299 66.12
2025-05-06BUY19,73059.64062.060 61.818USD 1,219,669 66.45
2025-05-05BUY19,73062.06062.830 62.753USD 1,238,117 66.68
2025-05-02BUY19,73062.03065.400 65.063USD 1,283,693 66.94
2025-05-01BUY19,73062.71063.620 63.529USD 1,253,427 67.18
2025-04-30BUY19,73063.69064.000 63.969USD 1,262,108 67.40
2025-04-29BUY19,73063.28064.080 64.000USD 1,262,720 67.68
2025-04-28BUY19,73062.98063.870 63.781USD 1,258,399 68.01
2025-04-25BUY19,73063.30063.440 63.426USD 1,251,395 68.38
2025-04-24BUY19,73062.74063.090 63.055USD 1,244,075 68.85
2025-04-23BUY19,73061.94063.390 63.245USD 1,247,824 69.47
2025-04-22BUY19,73061.50061.530 61.527USD 1,213,928 70.27
2025-04-21BUY19,73058.65059.910 59.784USD 1,179,538 71.56
2025-04-18BUY19,730 59.170* 73.11
2025-04-17BUY19,73059.17059.620 59.575USD 1,175,415 75.10
2025-04-16BUY19,73058.82060.460 60.296USD 1,189,640 77.82
2025-04-15BUY19,73060.02060.930 60.839USD 1,200,353 81.38
2025-04-14BUY19,73059.67059.990 59.958USD 1,182,971 86.80
2025-04-11BUY19,73056.82057.000 56.982USD 1,124,255 96.80
2025-04-10BUY19,73056.32058.330 58.129USD 1,146,885 117.03
2025-04-09BUY19,73059.43059.880 59.835USD 1,180,545 174.64
2025-04-08SELL-19,73055.89061.070 60.552USD -1,194,691 0.00 Loss of -1,194,691 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BMRN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19410,0268,500779,51352.6%
2025-09-18309,9349,272546,27156.7%
2025-09-17792,001761,198,91966.1%
2025-09-16481,50501,174,96941.0%
2025-09-15537,10968901,19259.6%
2025-09-12559,51941804,63869.5%
2025-09-11479,992858740,03264.9%
2025-09-10670,394301865,41977.5%
2025-09-09347,7870583,41259.6%
2025-09-08440,4270726,53560.6%
2025-09-05291,8700466,53662.6%
2025-09-04516,7790829,87862.3%
2025-09-03280,8020490,76857.2%
2025-09-02312,7570686,20245.6%
2025-08-29214,12613370,04357.9%
2025-08-28251,9167439,79557.3%
2025-08-27370,3496578,90564.0%
2025-08-26289,675233549,90452.7%
2025-08-25355,827100585,45360.8%
2025-08-22357,18416556,52864.2%
2025-08-21352,5011,525524,29367.2%
2025-08-20339,77774602,58956.4%
2025-08-19220,4370499,04144.2%
2025-08-18330,939435644,69651.3%
2025-08-15498,8220931,91353.5%
2025-08-14241,4360529,66845.6%
2025-08-13719,9923501,132,11263.6%
2025-08-12217,2424606,98935.8%
2025-08-11336,9850722,60446.6%
2025-08-08574,538391,320,70843.5%
2025-08-07387,50431837,24046.3%
2025-08-06571,71843896,31463.8%
2025-08-051,685,68712,5033,542,20047.6%
2025-08-041,579,75703,686,25742.9%
2025-08-01716,52602,200,77732.6%
2025-07-31549,45938925,08459.4%
2025-07-30718,573101,234,75558.2%
2025-07-29226,72575481,37547.1%
2025-07-28243,6265412,92959.0%
2025-07-25247,29586445,58755.5%
2025-07-24380,699137586,87264.9%
2025-07-23251,7130450,21955.9%
2025-07-22387,886114638,28360.8%
2025-07-21228,3756,803346,20866.0%
2025-07-18292,003100575,02850.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy